e-learning
resources
Stockholm 2007
Monday 17.09.2007
Congenital and acquired lung disorders: diagnostic and therapeutic indications in infants and children
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
PCD and CF – simultaneously?
E. Peterffy, A. Banfi, Z. Ecseki, G. Baktai (Budapest, Hungary)
Source:
Annual Congress 2007 - Congenital and acquired lung disorders: diagnostic and therapeutic indications in infants and children
Session:
Congenital and acquired lung disorders: diagnostic and therapeutic indications in infants and children
Session type:
Thematic Poster Session
Number:
2371
Disease area:
Paediatric lung diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Peterffy, A. Banfi, Z. Ecseki, G. Baktai (Budapest, Hungary). PCD and CF – simultaneously?. Eur Respir J 2007; 30: Suppl. 51, 2371
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Management of severe community acquired pneumonia – ERS guidelines
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Related content which might interest you:
PCD or asthma?
Source: Eur Respir J 2001; 18: Suppl. 33, 295s
Year: 2001
Why is adult CF care different?
Source: International Congress 2014 – ERS/European Cystic Fibrosis Society: “The provision of care for adults with cystic fibrosis (CF) in Europe"
Year: 2014
Measuring CFTR function in respiratory epithelial cell cultures: step to individualize treatments in cystic fibrosis?
Source: Virtual Congress 2021 – Monitoring of lung disease and CFTR function in children with cystic fibrosis
Year: 2021
CF lung disease starts in the peripheral airways. Does it?
Source: Annual Congress 2008 - Cystic fibrosis: new mechanisms, monitoring and treatment tools
Year: 2008
Bacterial biofilms in bronchiectasis of primary ciliary dyskinesia (PCD) in comparison with cystic fibrosis (CF)
Source: Annual Congress 2012 - Prognostic indices in respiratory infections
Year: 2012
Late diagnosis of CF: what should respiratory physicians be looking for?
Source: International Congress 2014 – ERS/European Cystic Fibrosis Society: “The provision of care for adults with cystic fibrosis (CF) in Europe"
Year: 2014
An assay of CF transmembrane conductance regulator function that uses primary CF intestinal organoids: shared experiences with the Russian CF centre
Source: International Congress 2018 – Russian Speaking Programme 2018: Part I
Year: 2018
How do we measure nasal NO in young children referred for PCD work up?
Source: Annual Congress 2008 - Clinical applications of ventilatory function tests in paediatric pulmonology
Year: 2008
Does the type of bacterial colonization in lower airways affect the lung function in patients with Primary Ciliary Dyskinesia (PCD)?
Source: Virtual Congress 2021 – Posters in paediatric bronchology
Year: 2021
Tezacaftor-ivacaftor for the treatment of cystic fibrosis: what’s next?
Source: International Congress 2018 – Therapeutic breakthroughs Year in Review
Year: 2018
The fate of lung fibrosis: Reversible or not?
Source: Lung Science Conference 2008 - Lung Injury, Repair and Remodelling
Year: 2008
Can AI help in detecting respiratory diseases with incomplete lung function data?
Source: Virtual Congress 2021 – Primary care diagnosis and multimorbidities
Year: 2021
What can we learn about pulmonary infection from studying the microbiome in CF?
Source: International Congress 2016 – What can respiratory medicine learn from cystic fibrosis research?
Year: 2016
PCD – As serious as CF in every day lung clinic?
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012
Does adventitious sound reflect the physiology of idiopathic pulmonary fibrosis (IPF)?
Source: Eur Respir J 2007; 30: Suppl. 51, 578s
Year: 2007
Why is COPD phenotyping like sorting diamonds?
Source: Eur Respir J 2014; 44: 277-279
Year: 2014
Difficult diagnosis of CF in the context of NBS: CFSPID
Source: ERS course 2015
Year: 2015
CF centre care-paediatrics
Source: ERS course 2015
Year: 2015
CF centre care-adults
Source: ERS course 2015
Year: 2015
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept